Biologicals

Japanese encephalitis

Proposed revision: Recommendations for Japanese Encephalitis Vaccine (inactivated) for human use

Expert Committee on Biological Standardization, Geneva, 8-12 October 2007

Japanese Encephalitis vaccine, inactivated

Title: Requirements for Japanese Encephalitis Vaccine (Inactivated) for Human Use; Adopted 1987, TRS No 771, Annex 6

Japanese encephalitis vaccine, live attenuated

Title: Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use, Adopted 2000, TRS 910, Annex 3

ESSENTIAL MEDICINES AND HEALTH PRODUCTS



NEW PUBLICATIONS

UPCOMING EVENTS


  • WHO Informal Consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products including biosimilars, Seoul, Republic of Korea, 27-28 April 2017
  • Working Group meeting on revision of WHO TRS 941, Annex 5: WHO biosafety risk assessment and Guidelines for the production and quality control of human influenza pandemic vaccines, Geneva, Switzerland, 9-10 May 2017
  • Working group meeting on Hepatitis E Vaccine, Geneva, Switzerland, 11-12 May 2017

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971